Harvoni TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: ledipasvir + sofosbuvir
Pack: Harvoni tablet, 28, bottle
Brand name
(ARTG)
: HARVONI ledipasvir/sofosbuvir 90 mg/400 mg tablet bottleDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
HARVONI (ledipasvir/sofosbuvir fixed-dose combination) is indicated for the treatment of chronic hepatitis C (CHC) infection in adults. (see PRECAUTIONS and CLINICAL TRIALS sections for information on the available data for HCV patients of each genotype, see DOSAGE AND ADMINISTRATION section for recommended regimens and treatment durations for different patient subgroups).
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, film coated
- Oral
- Film coated, orange, diamond shaped tablet with "GSI" on one side and "7985" on the other side
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Store at room temperature
- Shelf lifetime is 72 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 28 Tablets, Bottle pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient ledipasvir + sofosbuvir
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
